SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Anne Schultheis

Anne Schultheis

University Medical Center Freiburg, Freiburg

Prof. Dr. Anne Maria Schultheis is Professor of Pathology with a focus on Molecular Diagnostics at the University Medical Center Freiburg, Germany, where she heads molecular diagnostics at the Institute of Clinical Pathology. A molecular pathologist trained at Memorial Sloan Kettering Cancer Center and the University Hospital Cologne, her work centers on molecular profiling of non-small cell lung cancer, including driver alterations such as ALK, RET and EGFR, PD-L1 testing, resistance mechanisms, and AI-assisted diagnostic and prognostic algorithms. She speaks regularly at thoracic oncology meetings on next-generation sequencing and biomarker-directed diagnostics in lung cancer.

Connect

Anne Schultheis

Featured in

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates